Three Faculty Named UB Distinguished Professors
Published February 24, 2011 This content is archived.
Three of the five faculty members named UB Distinguished Professors for 2011 are in the School of Medicine and Biomedical Sciences.
The UB Distinguished Professor designation was created by the Office of the Provost to recognize full professors who have achieved distinction and are national or international leaders in their fields.
The new UB Distinguished Professors, whose accomplishments are described below, are:
- Paul R. Knight, III, MD, PhD, professor, Department of Anesthesiology, and director of the MD-PhD Program
- Teresa Quattrin, MD, A. Conger Goodyear Professor and chair of the Department of Pediatrics
- Stanley A. Schwartz, MD, PhD, professor, departments of Medicine, Pediatrics and Microbiology
Paul R. Knight, III, MD, PhD
Knight joined the UB faculty in 1992 as a professor of anesthesiology and microbiology and chair of the Department of Anesthesiology. He served as chair until 1998, when he stepped down to devote more time to research and clinical activities. He continues to maintain administrative duties in the department, serving as senior vice chair for research and director of the MD-PhD Program.
Knight’s research focuses on the effects of inhalation anesthetics on lung function, with specific emphasis on the relationship between anesthetics and viral infection, and the inflammatory process in lung tissue following the inhalation of vomit due to surgery or accidental causes.
A prolific scholar, he has published 115 papers in premier peer-review journals in the field, and was editor of the seventh edition of Wylie and Churchill-Davidson’s “A Practice of Anesthesia,” the premier textbook in anesthesiology. He has authored or co-authored 27 book chapters, including a chapter in “A Practice of Anesthesia.”
He has held appointments on numerous review committees and panels for the National Institutes of Health, the March of Dimes, the American Society of Anesthesiologists and the American Heart Association, among others. He has moderated and chaired scientific sessions at annual meetings of professional scientific societies, and has delivered more than 80 invited lectures on his specialty, as well as on his translational research, in this country and around the world.
He received the medical school’s 2010 Stockton Kimball Award for outstanding contributions to scholarship and to furthering the overall mission of the school.
Teresa Quattrin, MD
A UB faculty member since 1987, Quattrin also serves as pediatrician-in-chief at Women and Children’s Hospital of Buffalo, chief of the department’s Division of Endocrinology and Diabetes and director of the hospital’s Diabetes Center, which she established in 1990.
Quattrin is an internationally known expert in childhood diabetes and obesity. Her clinical practice and research focus on pediatric diabetes, insulin resistance, obesity and insulin-like growth factors.
Her research has been funded continuously since the mid-1980s, including grants from Eli Lilly, Genentech, Pfizer and the American Diabetes Association. She is the principal investigator on a $2.5 million NIH grant to study how family-based primary care can impact obesity in youth, and received one of five Type 2 Diabetes Center of Excellence grants from the New York State Department of Health to screen youth at increased risk of developing the disease.
Elected to the prestigious Society for Pediatric Research in 2003, Quattrin has delivered 14 national and three international invited lectures, and serves as associate editor of Diabetes Care, the premier journal in the field.
Stanley A. Schwartz, MD, PhD
A UB faculty since 1992, Schwartz also is director of the Division of Allergy, Immunology and Rheumatology in the medical school.
He studies the immunoregulatory process, immunodeficiency diseases and cancer, and is a leading authority on the relationship between drug abuse and AIDS.
For the past 15 years, he has received more than $7 million in NIH funding to study the effects of cocaine and heroin on immunological and neurological pathogenesis, including the brain disorders of encephalopathy associated with AIDS.
He has published 175 papers, most in top-ranked, peer-reviewed journals, and five book chapters; edited two books; and was guest editor for a volume of the Journal of Clinical Immunology devoted to immunoglobulin therapy—a key research area in which he is widely recognized.
Schwartz has received numerous honors for his work, including the Stockton Kimball Award, a UB Sustained Academic Achievement Award and the Meller Award for Outstanding Research from Memorial Sloan-Kettering Cancer Center.